Get started
Author

K. Hacène

Observed names: Hacene, K., K Hacene, K Hacène, K. HACENE, K. Hacene, K. Hacéne, Kamel Hacene, Kamel Hacène, Kamel Hacène, Kamel Hacéne
Observed institutions: Université de Sherbrooke, Inserm, Assistance Publique Hôpitaux de Marseille, Hôpital René Huguenin, Quebec Statistical Institute, Institut Curie
OpenAlex ID: A5110043435
Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
1989 · V. Le Doussal, M. Tubiana-Hulin, et al. · Cancer · 375
Cathepsin D: an Independent Prognostic Factor for Metastasis of Breast Cancer
1989 · Frédérique Spyratos, Kamel Hacene, et al. · The Lancet · 319
Prognostic Factors in Localized Primary Synovial Sarcoma: A Multicenter Study of 128 Adult Patients
2001 · Martine Trassard, Viviane Le Doussal, et al. · Journal of Clinical Oncology · 288
Anti-Colony-Stimulating Factor-1 Antibody Staining in Primary Breast Adenocarcinomas Correlates With Marked Inflammatory Cell Infiltrates and Prognosis
1994 · S. M. Scholl, C. Pallud, et al. · JNCI Journal of the National Cancer Institute · 226
Correlation between MIB‐1 and other proliferation markers
2002 · Frédérique Spyratos, Magali Ferrero‐Poüs, et al. · Cancer · 186
Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis
1996 · Viviane Le Doussal, Jean-Michel Coindre, et al. · Cancer · 180
PDF
A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors
2005 · Frédéric Triebel, Kamel Hacene, et al. · Cancer Letters · 176
Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer
1992 · I. Bièche, M.H. Champème, et al. · The Lancet · 166
[Sem: a suitable statistical software adaptated for research in oncology].
2000 · F Kwiatkowski, M Girard, et al. · PubMed · 156
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas
1994 · C Bouchet, F Spyratos, et al. · British Journal of Cancer · 156
PDF
Multiparametric Prognostic Evaluation of Biological Factors in Primary Breast Cancer
1992 · F. Spyratos, P.-M. Martin, et al. · JNCI Journal of the National Cancer Institute · 114
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study
2006 · J.M. Riedinger, J. Wafflart, et al. · Annals of Oncology · 103
PDF
Management and clinical outcomes of pregnant patients with invasive cervical cancer
2005 · N. Germann, C. Haie-Meder, et al. · Annals of Oncology · 100
Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
2000 · M Ferrero-Poüs, K Hacène, et al. · PubMed · 85
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography.
2005 · M F Pichon, F Cvitkovic, et al. · PubMed · 71
Dissemination Risk Index Based on Plasminogen Activator System Components in Primary Breast Cancer
1999 · Cécile Bouchet, Kamel Hacène, et al. · Journal of Clinical Oncology · 60
Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma
1991 · Philippe Bougnoux, Véronique Chajes, et al. · Breast Cancer Research and Treatment · 59
Immunohistochemistry on Cell Blocks From Fine-Needle Cytopunctures of Primary Breast Carcinomas and Lymph Node Metastases
2000 · Marianne Briffod, Kamel Hacène, et al. · Modern Pathology · 57
PDF
Enzyme-linked immunosorbent assay of ps2 in breast cancers, benign tumors, and normal breast tissues correlation with prognosis and adjuvant hormone therapy
1992 · J. Predine Mpharm, F. Spyratos Mpharm, et al. · Cancer · 57
PDF
Epidermal growth factor receptors and prognosis in primary breast cancer
1990 · Frédérique Spyratos, Jean-Claude Delarue, et al. · Breast Cancer Research and Treatment · 55
Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours
1991 · D Foucré, C Bouchet, et al. · British Journal of Cancer · 45
PDF
Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer
1989 · F. Spyratos, K. Hacene, et al. · European Journal of Cancer and Clinical Oncology · 44
Nuclear characteristics as indicators of prognosis in node negative breast cancer patients
1989 · V. le Doussal, M. Tubiana-Hulin, et al. · Breast Cancer Research and Treatment · 40
Prognostic Value of CA 15.3 Kinetics for Metastatic Breast Cancer
2002 · B. De La Lande, K. Hacene, et al. · The International Journal of Biological Markers · 39
Prognostic index for clinical Stage I cutaneous malignant melanoma.
1983 · K Hacene, V Le Doussal, et al. · PubMed · 39
Works count: 96
Citation count: 3,922
H-index: 31
I10-index: 55
Year
Topic
Type